shortage semaglutide Ozempic and Wegovy are no longer in shortage, FDA says On February 21, 2025, the
Description
Contrary to common knowledge, patients in the subgroup with a higher BMI did not show significant weight gain (WMD = 1.21 kg, 95% CI 1.24 to 3.60, P = 0.33, I 2 = 72%) and there were no significant differences between the subgroups ( P = 0.73) (Additional file 2: Fig
Sleep disturbances are another common concern
Association with a haplotype of class II human leukocyte antigen and synthesis of autoantibodies
Even more concerning, 29% of those patients had their TSH suppressed below the normal range, putting them at risk for iatrogenic hyperthyroidism
